Similar Articles
Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning
İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi
DOI: 10.55697/tnd.2024.107
The relationship between lesion volume, oligoclonal bands, and cerebrospinal fluid/serum albumin ratio in multiple sclerosis
Güllü Tarhan, Burçe Akbağra Kaya, Arif Musab Akıner, Yaren Betül Yılmaz, Saime Füsun Domaç
DOI: 10.55697/tnd.2024.88
The effect of demographic features and environmental risk factors on the clinical course in patients with multiple sclerosis
İrem İlgezdi Kaya, Bedile İrem Tiftikçioğlu, Yaşar Zorlu, Levent Öcek, Ufuk Şener, Figen Tokuçoğlu
DOI: 10.55697/tnd.2025.211
The effect of dual-tasking on functional mobility and manual dexterity in people with multiple sclerosis at different stages of disability
Çağrı Gülşen, Fatma Aydın, Fatih Söke, Bilge Koçer, Elvan Özcan Gülşen, Öznur Yilmaz, Selim Selçuk Çomoğlu
DOI: 10.55697/tnd.2025.265
Cognitive functions in radiologically isolated syndrome
Pelin Soydar, Hatice Mavioğlu
DOI: 10.55697/tnd.2025.262
Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19
Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer
DOI: 10.55697/tnd.2025.347
Alemtuzumab-induced antineutrophil cytoplasmic antibody-associated nephritis in a patient with multiple sclerosis
Furkan Sarıdaş, Saide Elif Güllülü Boz, Belkıs Nihan Coşkun, Emine Rabia Koç, Abdulmecit Yıldız, Berna Aytaç Vuruşkan, Ömer Faruk Turan
DOI: 10.55697/tnd.2024.238
Redefining multiple sclerosis: 2024 McDonald diagnostic criteria
Hazal Ceren Manazoğlu, Murat Kürtüncü
DOI: 10.55697/tnd.2025.500
Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study
Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva
DOI: 10.55697/tnd.2025.494
Bibliometric analysis on trends and future direction of facioscapulohumeral muscular dystrophy research
Fatma Yardibi, Ceren Hangül, Chen Chaomei
DOI: 10.55697/tnd.2025.428
Long-term cladribine experience in relapsing-remitting multiple sclerosis
Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç
DOI: 10.55697/tnd.2025.293
Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis
Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi
DOI: 10.55697/tnd.2025.323
Audiovestibular findings according to the subtypes of multiple sclerosis
Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz
DOI: 10.55697/tnd.2025.442
Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning
Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş
DOI: 10.55697/tnd.2025.511
Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis
Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci
DOI: 10.55697/tnd.2026.622